Literature DB >> 10544098

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.

K Nagayama1, M Kurosaki, N Enomoto, S Y Maekawa, Y Miyasaka, J Tazawa, N Izumi, F Marumo, C Sato.   

Abstract

The activity of hepatitis varies in chronic hepatitis C virus (HCV) infection. Some patients show persistently normal serum alanine aminotransferase (ALT) values, whereas the others show high-ALT values and progress to liver cirrhosis or hepatocellular carcinoma. However, virological mechanisms causing hepatitis have not fully been elucidated. We analyzed serial changes in full-length HCV sequences in 10 patients with various profiles of hepatitis activity. In the nonstructural 5A (NS5A) and NS5B, the rate of amino acid changes, as well as the proportion of nonsilent ones, was low in patients with normal ALT values compared with those with abnormal ALT (for the rate of amino acid changes, 0 x 10(-3) vs 3.19 x 10(-3) changes/site/year (P = 0.037) in NS5A and 0 x 10(-3) vs 1.22 x 10(-3) changes/site/year (P = 0.023) for NS5B, for the proportion of nonsilent changes, 4 vs 22% (P = 0.017) in NS5A and 0 vs 16% (P = 0. 039) in NS5B). Also, the flare-up of hepatitis coincided with higher nucleotide/amino acid substitution rates in NS5B. In conclusion, the genomic structures of the NS5A and NS5B regions may correlate with hepatitis activity in chronic hepatitis C. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544098     DOI: 10.1006/viro.1999.9924

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Functional characterization of core genes from patients with acute hepatitis C virus infection.

Authors:  Xi Tang; Jessica Wagoner; Amina Negash; Michael Austin; John McLauchlan; Young S Hahn; Hugo R Rosen; Stephen J Polyak
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

2.  Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients.

Authors:  B Cabot; M Martell; J I Esteban; M Piron; T Otero; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

4.  Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.

Authors:  Takumi Kawaguchi; Takafumi Yoshida; Masaru Harada; Takao Hisamoto; Yumiko Nagao; Tatsuya Ide; Eitaro Taniguchi; Hiroto Kumemura; Shinichiro Hanada; Michiko Maeyama; Shinji Baba; Hironori Koga; Ryukichi Kumashiro; Takato Ueno; Hisanobu Ogata; Akihiko Yoshimura; Michio Sata
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  High levels of subgenomic HCV plasma RNA in immunosilent infections.

Authors:  Flavien Bernardin; Susan L Stramer; Barbara Rehermann; Kimberly Page-Shafer; Stewart Cooper; David R Bangsberg; Judith Hahn; Leslie Tobler; Michael Busch; Eric Delwart
Journal:  Virology       Date:  2007-05-09       Impact factor: 3.616

6.  Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma.

Authors:  Sarah L Fishman; Stephanie H Factor; Cinzia Balestrieri; Xiaofeng Fan; Adrian M Dibisceglie; Suresh M Desai; Gary Benson; Andrea D Branch
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

7.  Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression.

Authors:  Mika Miura; Shinya Maekawa; Shinichi Takano; Nobutoshi Komatsu; Akihisa Tatsumi; Yukiko Asakawa; Kuniaki Shindo; Fumitake Amemiya; Yasuhiro Nakayama; Taisuke Inoue; Minoru Sakamoto; Atsuya Yamashita; Kohji Moriishi; Nobuyuki Enomoto
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

8.  Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients.

Authors:  K Nagayama; N Enomoto; N Izumi; M Kurosaki; Y Miyasaka; H Watanabe; J Itakura; C H Chen; J Tazawa; Y Hoshino; T Ikeda; F Marumo; C Sato
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

9.  Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.

Authors:  Takafumi Yoshida; Toshikatsu Hanada; Takeshi Tokuhisa; Ken-ichiro Kosai; Michio Sata; Michinori Kohara; Akihiko Yoshimura
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

10.  Coevolution analysis of Hepatitis C virus genome to identify the structural and functional dependency network of viral proteins.

Authors:  Raphaël Champeimont; Elodie Laine; Shuang-Wei Hu; Francois Penin; Alessandra Carbone
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.